Calando Pharmaceuticals Inc Pasadena, CA - 91106

Calando Pharmaceuticals Inc is categorized under Commercial Biotechnical Research in Pasadena, CA and active since 2008.

Calando Pharmaceuticals Inc was established in 2008, and today employs 1 to 4, earning Unknown per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.

If you are seeking more information, feel free to contact Larry G Stambaugh at the company’s single location by writing to 129 North Hill Avenue # 104, Pasadena, California CA 91106 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Calando Pharmaceuticals Inc
Contact Person: Larry G Stambaugh
Address: 129 North Hill Avenue # 104, Pasadena, California 91106
Website Address: arrowheadresearch.com
Annual Revenue (USD): Unknown
Founded: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Biotechnical Research
SIC Code: 8731
NAICS Code: 541711
Share This Business:

Calando Pharmaceuticals Inc was started in 2008 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Larry G Stambaugh for inquiries that concern Calando Pharmaceuticals Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Calando Pharmaceuticals Inc can be found at the coordinates as well as the street address 129 North Hill Avenue # 104 in Pasadena, California 91106.

For its online presence, you may visit Calando Pharmaceuticals Inc’s website at arrowheadresearch.com and engage with its social media outlets through on Twitter and on Facebook.